The UK National Prescribing Centre (NPC) has published a MeReC Bulletin (PDF) that summarises the current recommendations for assessing and communicating the risk of cardiovascular disease (CVD).
The bulletin aids the implementation of the recent Lipid Modification issued by the National Institute for Health and Clinical Excellence (NICE). It covers the following:
Which CVD risk prediction tool to use
Identification of individuals appropriate for risk assessment
How to formally assess CV risk
How to calculate CV risk for patients with type 2 diabetes
How to communicate the calculated CV risk to patients
Thanks Matt, http://www.prescriber.org.uk/
No comments:
Post a Comment